Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07231484 · ClinicalTrials.gov registry record · NA

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

A NA study of Obesity &Amp; Overweight, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07231484 is a NA study of Obesity &Amp; Overweight that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 50 participants, below the 99-participant average among 8 other Obesity &Amp; Overweight trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07231484, a NA study of Obesity &Amp; Overweight, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.

Conditions Studied

Interventions

  • OTHER Freeze-dried grape powder
  • OTHER Placebo powder

Study Locations (1)

Missouri

  • University of Missouri-Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-19
Est. Completion 2027-12-30
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT07231484

The ClinicalTrials.gov registry entry for NCT07231484 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 8 other Obesity &Amp; Overweight trials with a reported enrollment target (49% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity &Amp; Overweight appearing as the primary indexed condition, and to 2 interventions - of which Freeze-dried grape powder is the first listed.

NCT07231484 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT07231484 about?

NCT07231484 is a clinical study titled "Effects of Grape Consumption on the Immune-Gut Axis in Obesity". This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.

What is the current status of trial NCT07231484?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-19. Estimated completion is 2027-12-30.

What conditions does trial NCT07231484 study?

This clinical trial studies the following conditions: Obesity &Amp; Overweight.

What interventions are being tested in trial NCT07231484?

The interventions under investigation include: Freeze-dried grape powder (OTHER), Placebo powder (OTHER).

Who is sponsoring clinical trial NCT07231484?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07231484 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity &Amp; Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.